FDA.reportPublic FDA data

24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]

RxCUI
2743035
RxNorm name
24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Display name
24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Full name
24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f1c82580-87ae-11e0-bc84-0002a5d5c51b24 HR ruxolitinib 44 MG Extended Release Oral Tablet [Jakafi]SBD40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51bJakafi XR 44 MG 24 HR Extended Release Oral TabletSY40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51bJakafi XR 44 MG 24HR Extended Release Oral TabletPSN40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501